Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Advertisement

Advertisement




Jun
16
Today In Oncology
Neoadjuvant Sacituzumab Govitecan in MIBC
Thyroid Cancer Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence
Two-Pronged Nudges Result in Timely Conversations Around Priorities of Cancer Care
MIBC Intravesical Recombinant BCG and Chemoimmunotherapy
Overall Survival Benefit With Ivonescimab Plus Chemotherapy in Advanced Squamous NSCLC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo